查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1691808

血液製剂市场 - 全球产业规模、份额、趋势、机会和预测，按产品、类型、应用区域和竞争细分，2020-2030 年

Blood Preparation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By Application Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球血液製剂市场价值为 435.7 亿美元，预计到 2030 年将达到 625.7 亿美元，预测期内复合年增长率为 6.22%。全球血液製备市场是医疗保健和製药行业一个充满活力且至关重要的组成部分，涵盖广泛的产品和服务，旨在确保各种医疗应用中血液和血液相关产品的可用性和安全性。该市场围绕着血液成分、血浆和其他血液衍生物的加工、测试和分销，对于救命的输血、治疗和研究至关重要。随着对病人安全的日益重视，对先进、高品质的血液製备产品和服务的需求也稳步增长。

市场概况
预测期 2026-2030
2024 年市场规模 435.7 亿美元
2030 年市场规模 625.7 亿美元
2025-2030 年复合年增长率 6.22%
成长最快的领域 血液衍生物
最大的市场 北美洲

主要市场驱动因素

慢性病盛行率

主要市场挑战

严格遵守法规

主要市场趋势

血液製备技术的进步

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第四章：全球血液製剂市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 副产品（全血、血液成分、血液衍生物）
    • 按类型（血小板聚集抑制剂、纤维蛋白溶解剂、抗凝血剂）
    • 依用途分类（血栓形成、肺栓塞、肾功能不全、心绞痛血管併发症、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图
    • 按产品
    • 按类型
    • 按应用
    • 按地区

第五章：亚太血液製剂市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按产品
    • 按类型
    • 按应用
    • 按国家
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国

第六章：欧洲血液製剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 西班牙
    • 义大利
    • 英国

第 7 章：北美血液製剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 墨西哥
    • 加拿大

第 8 章：南美洲血液製剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第九章：中东和非洲血液製剂市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 10 章：市场动态

  • 驱动程式
  • 挑战

第 11 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 合併与收购

第 12 章：全球血液製剂市场：SWOT 分析

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • Pfizer, Inc.
  • Bristol-Myers Squibb Company
  • Leo Pharma A/S
  • Sanofi
  • Xiamen Hisunny Chemical Co., LTD
  • AstraZeneca plc
  • Baxter International Inc
  • Portola Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Shandong East Chemical Industry Co.

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 20728

Global Blood Preparation Market was valued at USD 43.57 billion in 2024 and is expected to reach USD 62.57 billion by 2030 with a CAGR of 6.22% during the forecast period. The Global Blood Preparation Market is a dynamic and critical component of the healthcare and pharmaceutical industry, encompassing a wide range of products and services aimed at ensuring the availability and safety of blood and blood-related products for various medical applications. This market revolves around the processing, testing, and distribution of blood components, plasma, and other blood derivatives, vital for life-saving transfusions, therapeutic treatments, and research. With a growing emphasis on patient safety, the demand for advanced and high-quality blood preparation products and services has been steadily increasing.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 43.57 Billion
Market Size 2030USD 62.57 Billion
CAGR 2025-20306.22%
Fastest Growing SegmentBlood Derivatives
Largest MarketNorth America

Key Market Drivers

Prevalence of Chronic Diseases

The prevalence of chronic diseases is a primary driver behind the rapid growth of the Global Blood Preparation Market. Chronic diseases, which encompass a wide range of conditions such as cancer, anemia, hemophilia, and blood disorders, often necessitate frequent blood transfusions as an integral part of their management and treatment. This demand for blood and blood-related products is escalating due to the increasing global burden of chronic diseases.

As populations age and lifestyles become increasingly sedentary, the incidence of chronic diseases continues to rise. Conditions like diabetes, cardiovascular diseases, and cancer have become more common, leading to a growing need for blood preparations. For instance, cancer patients often require regular blood transfusions to manage the anemia and low platelet counts associated with chemotherapy, while individuals with blood disorders like sickle cell anemia depend on blood transfusions to alleviate their symptoms and complications.

Key Market Challenges

Stringent Regulatory Compliance

The Global Blood Preparation Market, a crucial pillar of healthcare, faces a formidable challenge in the form of stringent regulatory compliance. While regulations are essential to ensuring the safety and efficacy of blood and blood-related products, the stringent nature of these requirements can impede the market's growth and operational efficiency.

Blood preparation involves a complex set of processes, from collection and testing to storage and distribution. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), set stringent standards that must be met to guarantee the safety and quality of blood products. These standards encompass numerous facets of the blood preparation process, including donor eligibility criteria, testing protocols, documentation, and the maintenance of storage and transportation conditions.

Meeting these rigorous regulatory requirements can be a resource-intensive endeavor, particularly for smaller blood banks and healthcare providers. Compliance demands substantial investments in state-of-the-art equipment, quality control measures, staff training, and infrastructure. These expenses can be cost-prohibitive for smaller organizations, potentially limiting their ability to participate in the market. Furthermore, the constant need to adapt to evolving regulations places an ongoing financial burden on stakeholders within the blood preparation industry.

Key Market Trends

Technological Advancements in Blood Preparation

Technological advancements in blood preparation are playing a pivotal role in boosting the Global Blood Preparation Market. Automation, sophisticated equipment, and innovative methods have ushered in a new era of efficiency, safety, and quality within the industry. These advancements are reshaping the landscape of blood collection, processing, and storage, leading to an enhanced market with numerous benefits for healthcare providers and patients alike.

Automation, in particular, stands out as a game-changer in the field. Automated blood preparation systems have revolutionized the industry by significantly reducing human error, enhancing precision, and accelerating the speed at which blood components can be prepared. Automated equipment can process large volumes of blood with unmatched precision, resulting in a more consistent and reliable supply of blood products. This not only improves operational efficiency but also reduces the margin of error, ensuring that the final products meet the highest quality and safety standards.

Moreover, innovative methods and technologies have paved the way for more advanced testing and screening processes. The introduction of nucleic acid testing (NAT), for instance, has significantly enhanced the sensitivity and accuracy of detecting infectious agents, such as HIV, hepatitis B and C. This improvement in blood safety has instilled greater confidence among healthcare professionals and the public, reassuring them that blood products are less likely to transmit infections or other complications.

Key Market Players

  • Pfizer, Inc.
  • Bristol-Myers Squibb Company
  • Leo Pharma A/S
  • Sanofi
  • Xiamen Hisunny Chemical Co., LTD
  • AstraZeneca plc
  • Baxter International Inc
  • Portola Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Shandong East Chemical Industry Co.

Report Scope:

In this report, the Global Blood Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Preparation Market, By Product:

  • Whole Blood
  • Blood Components
  • Blood Derivatives

Blood Preparation Market, By Type:

  • Platelet Aggregation Inhibitors
  • Fibrinolytics
  • Anticoagulants

Blood Preparation Market, By Application:

  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others

Blood Preparation Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Preparation Market.

Available Customizations:

Global Blood Preparation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Blood Preparation Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product (Whole Blood, Blood Components, Blood Derivatives)
    • 4.2.2. By Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants)
    • 4.2.3. By Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, Others)
    • 4.2.4. By Region
    • 4.2.5. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Product
    • 4.3.2. By Type
    • 4.3.3. By Application
    • 4.3.4. By Region

5. Asia Pacific Blood Preparation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Type
    • 5.2.3. By Application
    • 5.2.4. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Blood Preparation Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Product
        • 5.3.1.2.2. By Type
        • 5.3.1.2.3. By Application
    • 5.3.2. India Blood Preparation Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Product
        • 5.3.2.2.2. By Type
        • 5.3.2.2.3. By Application
    • 5.3.3. Australia Blood Preparation Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Product
        • 5.3.3.2.2. By Type
        • 5.3.3.2.3. By Application
    • 5.3.4. Japan Blood Preparation Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Product
        • 5.3.4.2.2. By Type
        • 5.3.4.2.3. By Application
    • 5.3.5. South Korea Blood Preparation Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Product
        • 5.3.5.2.2. By Type
        • 5.3.5.2.3. By Application

6. Europe Blood Preparation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Blood Preparation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
    • 6.3.2. Germany Blood Preparation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
    • 6.3.3. Spain Blood Preparation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application
    • 6.3.4. Italy Blood Preparation Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By Type
        • 6.3.4.2.3. By Application
    • 6.3.5. United Kingdom Blood Preparation Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By Type
        • 6.3.5.2.3. By Application

7. North America Blood Preparation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Blood Preparation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
    • 7.3.2. Mexico Blood Preparation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
    • 7.3.3. Canada Blood Preparation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application

8. South America Blood Preparation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Blood Preparation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
    • 8.3.2. Argentina Blood Preparation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
    • 8.3.3. Colombia Blood Preparation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application

9. Middle East and Africa Blood Preparation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Blood Preparation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
    • 9.3.2. Saudi Arabia Blood Preparation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
    • 9.3.3. UAE Blood Preparation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Blood Preparation Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Pfizer, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Bristol-Myers Squibb Company
  • 14.3. Leo Pharma A/S
  • 14.4. Sanofi
  • 14.5. Xiamen Hisunny Chemical Co., LTD
  • 14.6. AstraZeneca plc
  • 14.7. Baxter International Inc
  • 14.8. Portola Pharmaceuticals, Inc.
  • 14.9. GlaxoSmithKline PLC
  • 14.10.Shandong East Chemical Industry Co.

15. Strategic Recommendations

16. About Us & Disclaimer